-67%

est. 2Y upside i

Healthcare

Training patients and their families with health skills

Rank

#2277

Sector

Healthcare Training/Support Services

Est. Liquidity

~3Y

Data Quality

Data: Medium

Noora Health presents a unique equity opportunity driven by its significant social impact, strong partnerships with governments and the WHO, and a proven model for improving health outcomes.

Last updated: February 24, 2026

Bull (30%)+150%

Noora Health successfully leverages its WHO partnership and government integrations to significantly scale its programs, achieves profitability, and attracts a strategic acquisition or a large impact investment round.

Base (35%)+40%

Noora Health continues its strong operational growth and expands existing partnerships, but profitability remains elusive, leading to a modest valuation increase.

Bear (35%)-50%

Noora Health struggles to secure additional funding to cover its burn rate, faces challenges in scaling government partnerships, or experiences a valuation reset due to persistent unprofitability.

Est. time to liquidity~3.0 years

Preference Stack Risk

low

The majority of Noora Health's $52M in total funding comes from grants, which do not create liquidation preferences for equity holders. A small seed round from 2014 for an undisclosed amount is the only identified equity funding, making the investor preference stack negligible.

Dilution Risk

moderate

Given the current unprofitability and reliance on future funding, Noora Health will likely need to raise additional capital, which could lead to employee equity dilution.

Secondary Liquidity

none

As a private company with a non-traditional funding history, there is currently no active secondary market or tender offers for Noora Health's equity.

Community

Valuation Sentiment

Our model estimates -67% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.